Fundraising Fox
/Companies
Sign in

C the Signs

Founded 2017 · 2 known investors

Find your way into C the Signs

Sign up to see every warm intro you have to C the Signs

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the C the Signs team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

C the Signs develops AI-powered tools for early cancer detection using real-time data and evidence-based pathways. The platform is designed for healthcare systems and clinicians to improve patient outcomes through earlier diagnosis across all populations.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Founders & leadership

C the Signs was founded in 2017 by Bea Bakshi and Miles Payling.

BBBea Bakshi
Bea BakshiCo-founder
MPMiles Payling
Miles PaylingCo-founder
DB
Dr Bhavagaya Bakshi, MDCo-founder & CEO
DM
Dr Miles Payling, MDCo-founder and Chief Scientific Officer

Investors · 2

MMC Ventureslisted by MMC VenturesLondon · $635K – $13M

How we know: MMC Ventures's portfolio page · Not right? Tell us

Funding

SEC filings, press & company announcements

$8M disclosed across 1 of 3 rounds · 2022–2025

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 2

CancerresearchukCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
American Cancer Society (ACS)The American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities. It serves individuals seeking cancer information and those who want to support cancer research and patient advocacy efforts.

Companies working in the same space as C the Signs.

Companies House · registry record

View on Companies House ↗
Registered name
C THE SIGNS LIMITED
Company number
10683539
Status
Active
Company type
Private limited company
Incorporated
22 Mar 2017
Registered office
Gridiron Building, 1 Pancras Square, London, N1C 4AG
Nature of business (SIC)
62090 — Other information technology service activities86900 — Other human health activities
Accounts
last made up to 31 Mar 2025 · next due 31 Dec 2026
Confirmation statement
last made up to 28 Feb 2026 · next due 14 Mar 2027

Current officers · 3

  • Bhavagaya Bakshi — director, appointed 22 Mar 2017
  • Miles Payling — director, appointed 22 Mar 2017
  • Todd Curtis Rothenhaus — director, appointed 17 Apr 2024

Source: Companies House public register · retrieved 27 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

C the Signs Raises $8M in Fundingfinsmes.com · Jan 2025

Frequently asked questions

What does C the Signs do?
C the Signs develops AI-powered tools for early cancer detection using real-time data and evidence-based pathways. The platform is designed for healthcare systems and clinicians to improve patient outcomes through earlier diagnosis across all populations.
Who founded C the Signs?
C the Signs was founded by Bea Bakshi, Miles Payling in 2017.
Who are C the Signs's investors?
C the Signs's investors include Khosla Ventures, MMC Ventures.
How much funding has C the Signs raised?
C the Signs has disclosed $8M raised across 1 of its 3 known rounds.